- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06208891
Clinical Outcomes of Robotic Myomectomy
January 5, 2024 updated by: Sheng-Mou Hsiao, Far Eastern Memorial Hospital
Clinical Outcomes of Robotic Myomectomy: Comparisons of Without Versus With Temporary or Permanent Uterine Artery Occlusion.
To identify the predictors of perioperative outcomes in women who receive robotic myomectomy
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Uterine myoma is the most common gynecological tumor.
Current surgical management was inclusive of conventional abdominal myomectomy, laparoscopy-assisted myomectomy, robotic-assisted myomectomy.
The aim of this study was to identify the predictors of perioperative outcomes in women who receive robotic myomectomy
Study Type
Observational
Enrollment (Estimated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Taipei
-
Banqiao, New Taipei, Taiwan, 22050
- Recruiting
- Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
-
Contact:
- Sheng-Mou Hsiao, M.D.
- Phone Number: 1818 +886-2-89667000
- Email: smhsiao2@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Women who received robotic-assisted myomectomy
Description
Inclusion criteria
- >20 years old women
- women who received robotic myomectomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Robotic myomectomy
Women who received robotic myomectomy
|
Robotic assisted laparoscopic myomectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Surgical time
Time Frame: 1 week
|
Factors (e.g., the location and largest diameter of the uterine myoma) predicting surgical time
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative blood loss
Time Frame: 1 week
|
Factors (e.g., the location and largest diameter of the uterine myoma) predicting intraoperative blood loss
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 21, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
December 5, 2023
First Submitted That Met QC Criteria
January 5, 2024
First Posted (Estimated)
January 17, 2024
Study Record Updates
Last Update Posted (Estimated)
January 17, 2024
Last Update Submitted That Met QC Criteria
January 5, 2024
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 112185-E
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Women With Uterine Myoma
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingUterine Sarcoma | Uterine MyomaItaly
-
Ospedale Policlinico San MartinoRecruitingUterine Fibroids | Uterine MyomasItaly
-
Halic UniversityCompletedWomen With Low Sexual Satisfaction | Partners of Women With Low Sexual SatisfactionTurkey
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedWomen With Abnormal Pap SmearsUnited States
-
PregLem SACompletedUterine MyomasCzech Republic, Hungary, India, Romania, Russian Federation, Ukraine
-
University Hospital, BrestCompletedUterine Anteflexion | Parous WomenFrance
-
PregLem SACompletedUterine MyomasSpain, Germany, Austria, Israel, Poland, Italy, Belgium, France, Netherlands
-
University Magna GraeciaJohnson & JohnsonCompleted
-
Mansoura UniversityCompletedthe Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine AdenomyosisEgypt
-
Tehran University of Medical SciencesUnknownWomen With PMSIran, Islamic Republic of
Clinical Trials on Robotic myomectomy
-
Taipei Medical University Shuang Ho HospitalTaipei Medical University WanFang Hospital; Tri-Service General Hospital; Asian...Not yet recruitingSurgical Procedure, Unspecified | Uterine LeiomyomaTaiwan
-
Far Eastern Memorial HospitalRecruitingHysteroscopic MyomectomyTaiwan
-
CHA UniversityCompleted
-
Bilge HospitalCompletedCesarean Section ComplicationsTurkey
-
Mansoura UniversityUnknownInfertility | FibroidEgypt
-
Mansoura UniversityCompletedCesarean Section | Uterine Fibroid
-
Cairo UniversityCompleted
-
Mansoura UniversityZagazig University; Alexandria University; Assiut University; Sohag UniversityUnknown
-
Helsinki University Central HospitalUniversity of HelsinkiUnknownQuality of Life | Genetics | Uterine Myomectomy | Gynecologic Surgical ProceduresFinland
-
Ain Shams UniversityNot yet recruitingLAZMAR Scoring , Hysteroscopic Myomectomy